ES2334084B1 - Marcadores geneticos para el pronostico de la esclerosis multiple. - Google Patents

Marcadores geneticos para el pronostico de la esclerosis multiple. Download PDF

Info

Publication number
ES2334084B1
ES2334084B1 ES200703415A ES200703415A ES2334084B1 ES 2334084 B1 ES2334084 B1 ES 2334084B1 ES 200703415 A ES200703415 A ES 200703415A ES 200703415 A ES200703415 A ES 200703415A ES 2334084 B1 ES2334084 B1 ES 2334084B1
Authority
ES
Spain
Prior art keywords
multiple sclerosis
genes
expression
patient
subjects suffering
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn - After Issue
Application number
ES200703415A
Other languages
English (en)
Other versions
ES2334084A1 (es
Inventor
Diaz Pablo Villoslada
Martinez Antonio Martinez
Buela Laureano Simon
Urtasun Ricardo Palacios
Bernad Jorge Sepulcre
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Progenika Biopharma SA
Instituto Cientifico y Tecnologico de Navarra SA
Original Assignee
Progenika Biopharma SA
Instituto Cientifico y Tecnologico de Navarra SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Progenika Biopharma SA, Instituto Cientifico y Tecnologico de Navarra SA filed Critical Progenika Biopharma SA
Priority to ES200703415A priority Critical patent/ES2334084B1/es
Priority to US12/809,726 priority patent/US20130184167A1/en
Priority to PCT/ES2008/000785 priority patent/WO2009080849A2/es
Priority to EP08865077A priority patent/EP2233586A4/en
Publication of ES2334084A1 publication Critical patent/ES2334084A1/es
Application granted granted Critical
Publication of ES2334084B1 publication Critical patent/ES2334084B1/es
Withdrawn - After Issue legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • Data Mining & Analysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Databases & Information Systems (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
ES200703415A 2007-12-21 2007-12-21 Marcadores geneticos para el pronostico de la esclerosis multiple. Withdrawn - After Issue ES2334084B1 (es)

Priority Applications (4)

Application Number Priority Date Filing Date Title
ES200703415A ES2334084B1 (es) 2007-12-21 2007-12-21 Marcadores geneticos para el pronostico de la esclerosis multiple.
US12/809,726 US20130184167A1 (en) 2007-12-21 2008-12-18 Genetic markers for the prognosis of multiple sclerosis
PCT/ES2008/000785 WO2009080849A2 (es) 2007-12-21 2008-12-18 Marcadores genéticos para el pronóstico de la esclerosis múltiple
EP08865077A EP2233586A4 (en) 2007-12-21 2008-12-18 GENETIC MARKERS FOR THE PROGNOSIS OF MULTIPLE SCLEROSIS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200703415A ES2334084B1 (es) 2007-12-21 2007-12-21 Marcadores geneticos para el pronostico de la esclerosis multiple.

Publications (2)

Publication Number Publication Date
ES2334084A1 ES2334084A1 (es) 2010-03-04
ES2334084B1 true ES2334084B1 (es) 2011-01-24

Family

ID=40801620

Family Applications (1)

Application Number Title Priority Date Filing Date
ES200703415A Withdrawn - After Issue ES2334084B1 (es) 2007-12-21 2007-12-21 Marcadores geneticos para el pronostico de la esclerosis multiple.

Country Status (4)

Country Link
US (1) US20130184167A1 (es)
EP (1) EP2233586A4 (es)
ES (1) ES2334084B1 (es)
WO (1) WO2009080849A2 (es)

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE340870T1 (de) 1998-04-03 2006-10-15 Compound Therapeutics Inc Adressierbare protein arrays
WO1999054463A2 (en) * 1998-04-21 1999-10-28 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Human k+ ion channel and therapeutic applications thereof
US20060115826A1 (en) 1999-06-28 2006-06-01 Michael Bevilacqua Gene expression profiling for identification monitoring and treatment of multiple sclerosis
GB9928787D0 (en) 1999-12-03 2000-02-02 Medical Res Council Direct screening method
WO2002079218A1 (en) 2001-03-30 2002-10-10 Wyeth Methods for diagnosing and treating multiple sclerosis and compositions thereof
ATE485515T1 (de) 2001-06-22 2010-11-15 Burkhard Jansen Verfahren zur diagnose einer person mit multipler sklerose
WO2003023056A2 (en) 2001-09-12 2003-03-20 F. Hoffmann-La Roche Ag Specific markers for multiple sclerosis
WO2003081201A2 (en) 2002-03-21 2003-10-02 Yissum Research Development Company Of The Hebrew University Of Jerusalem Peripheral blood cell markers useful for diagnosing multiple sclerosis and methods and kits utilizing same
US20040018522A1 (en) 2002-05-09 2004-01-29 Brigham And Women's Hospital, Inc. Identification of dysregulated genes in patients with multiple sclerosis
US20060058225A1 (en) * 2002-05-31 2006-03-16 Mcgill University Used of inhibitors of phospholipase a2 for the treatment, prevention or diagnosis of neural inflammatory or demyelinating disease
JP3856734B2 (ja) * 2002-06-28 2006-12-13 株式会社日立製作所 多発性硬化症に対するインターフェロン・ベータ薬物治療の有効性予測方法
US20040091915A1 (en) 2002-07-30 2004-05-13 David Comings Methods for predicting survival rate in patients having multiple sclerosis
US20050064483A1 (en) 2003-08-28 2005-03-24 Baylor College Of Medicine Gene expression profiling technology for treatment evaluation of multiple sclerosis
US20090011407A1 (en) 2003-11-26 2009-01-08 The Ohio State University Research Foundation Polymorphic Cd24 Genotypes that are Predictive of Multiple Sclerosis Risk and Progression
JP2005160440A (ja) 2003-12-05 2005-06-23 Hitachi Ltd 多発性硬化症に関連する遺伝子の発現測定方法、多発性硬化症関連遺伝子の発現を測定するためのチップ、多発性硬化症の罹患を判断するための遺伝子群、多発性硬化症の評価方法
EP1550873A1 (en) * 2003-12-30 2005-07-06 Progenika Biopharma, S.A. Methods for the in vitro diagnosis and prognosis of demyelinating diseases and for the development of drugs against demyelinating diseases
EP2062981B1 (en) * 2005-06-16 2013-09-25 Life Technologies Corporation Gene expression profiling for identification and monitoring of multiple sclerosis

Also Published As

Publication number Publication date
WO2009080849A3 (es) 2009-09-17
EP2233586A2 (en) 2010-09-29
EP2233586A4 (en) 2011-02-09
US20130184167A1 (en) 2013-07-18
ES2334084A1 (es) 2010-03-04
WO2009080849A2 (es) 2009-07-02

Similar Documents

Publication Publication Date Title
Kumar et al. Circulating miRNA biomarkers for Alzheimer's disease
Mitchell et al. Comparison of depressive episodes in bipolar disorder and in major depressive disorder within bipolar disorder pedigrees
WO2008067551A3 (en) Genetic analysis systems and methods
WO2009116861A3 (en) Diagnostic of pre-symptomatic metabolic syndrome
Coppola et al. A gene expression phenotype in lymphocytes from Friedreich ataxia patients
ES2527592T3 (es) Métodos basados en microARN para el diagnóstico del cáncer de colon
WO2005000098A3 (en) Detection methods for disorders of the lung
DK1730315T3 (da) Polymorphismer i NOD2/Card15 gen
NO20084488L (no) Methods for the production of functional protein from DNA having a nonsense mutation and the treatment of disorders associated therewith
MX2012008730A (es) Metodos y composiciones para prediccion de riesgo, diagnosis, prognosis y tratamiento de desordenes pulmonares.
CN105358713A (zh) 与克罗恩病相关的tnfsf15和dcr3的变体
WO2008000186A8 (fr) Méthode d'identification d'un nouveau gène et nouveaux gènes résultants
T Compton et al. Conceptualizing the multifaceted determinants of the duration of untreated psychosis
WO2005118403A3 (en) Methods for detecting gene expression in peripheral blood cells and uses thereof
de Aguiar Ferreira et al. The role of 5-HTTLPR polymorphism in antidepressant-associated mania in bipolar disorder
Bonnín et al. Predictors of functional outcome after a manic episode
Fuying et al. Novel susceptibility genes were found in a targeted sequencing of stroke patients with or without depression in the Chinese Han population
ATE513929T1 (de) Gene mit einfluss auf die menschliche gedächtnisleistung
Blasco-Fontecilla et al. Predicting suicidal behavior: are we really that far along? Comment on “Discovery and validation of blood biomarkers for suicidality”
Landaas et al. No association between the serotonin transporter gene polymorphism 5-HTTLPR and cyclothymic temperament as measured by TEMPS-A
Connan et al. Personality disorder cognitions in the eating disorders
ES2334084B1 (es) Marcadores geneticos para el pronostico de la esclerosis multiple.
WO2009087689A3 (en) Novel primers for identification of astrocytoma, it's grades and glioblastoma prognosis
IT202000031061A1 (it) Uso di mirna come biomarcatori per la diagnosi e prognosi del carcinoma orale a cellule squamose
Jang et al. " Prediction model of conversion to dementia risk in subjects with amnestic mild cognitive impairment: A longitudinal, multi-center clinic-based study": Erratum.

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20100304

Kind code of ref document: A1

FG2A Definitive protection

Ref document number: 2334084

Country of ref document: ES

Kind code of ref document: B1

Effective date: 20110112

FA2A Application withdrawn

Effective date: 20110531